These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6514760)

  • 1. [Systemic availability of prednisolone following oral administration of prednisone].
    Frey BM; Brandenberger AW; Frey FJ; Widmer HR
    Pharm Acta Helv; 1984; 59(11):301-9. PubMed ID: 6514760
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacokinetic parameters of prednisone and prednisolone in healthy volunteers].
    Etienne SD; Vandermeersch V; Chosidow O; Vu-Thi-My-Le C; Godeau P; Diquet B; Herson S
    Ann Med Interne (Paris); 1990; 141(6):507-11. PubMed ID: 2285202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of smoking on prednisone, prednisolone, and dexamethasone pharmacokinetics.
    Rose JQ; Yurchak AM; Meikle AW; Jusko WJ
    J Pharmacokinet Biopharm; 1981 Feb; 9(1):1-14. PubMed ID: 7229914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dosages in oral and parenteral steroid therapy].
    Kaiser H
    Dtsch Med Wochenschr; 1973 Mar; 98(10):518. PubMed ID: 4691578
    [No Abstract]   [Full Text] [Related]  

  • 5. Prednisone and prednisolone bioavailability in renal transplant patients.
    Gambertoglio JG; Frey FJ; Holford NH; Birnbaum JL; Lizak PS; Vincenti F; Feduska NJ; Salvatierra O; Amend WJ
    Kidney Int; 1982 Apr; 21(4):621-6. PubMed ID: 7047863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect on nephrotic syndrome on absorption and disposition of prednisolone in children.
    Rocci ML; Assael BM; Appiani AC; Edefonti A; Jusko WJ
    Int J Pediatr Nephrol; 1982 Sep; 3(3):159-66. PubMed ID: 7141787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics of prednisone and prednisolone.
    Pickup ME
    Clin Pharmacokinet; 1979; 4(2):111-28. PubMed ID: 378499
    [No Abstract]   [Full Text] [Related]  

  • 8. Altered metabolism and decreased efficacy of prednisolone and prednisone in patients with hyperthyroidism.
    Frey FJ; Horber FF; Frey BM
    Clin Pharmacol Ther; 1988 Nov; 44(5):510-21. PubMed ID: 2972434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring prednisone and prednisolone.
    Jusko WJ; Rose JQ
    Ther Drug Monit; 1980; 2(2):169-76. PubMed ID: 6762710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prednisolone clearance: a possible determinant for glucocorticoid efficacy in patients with oral vesiculo-erosive diseases.
    Lozada F; Frey FJ; Benet LZ
    J Dent Res; 1983 May; 62(5):575-7. PubMed ID: 6573375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible metabolism and pharmacokinetics: application to prednisone-prednisolone.
    Wagner JG; DiSanto AR; Gillespie WR; Albert KS
    Res Commun Chem Pathol Pharmacol; 1981 Jun; 32(3):387-405. PubMed ID: 7268190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative bioavailability of prednisone and prednisolone in man.
    Tse FL; Welling PG
    J Pharm Pharmacol; 1979 Jul; 31(7):492-3. PubMed ID: 38330
    [No Abstract]   [Full Text] [Related]  

  • 13. Kinetics and interconversion of prednisolone and prednisone studied with new radioimmunogassays.
    Meikle AW; Weed JA; Tyler FH
    J Clin Endocrinol Metab; 1975 Oct; 41(4):717-21. PubMed ID: 1176582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative serum prednisone and prednisolone concentrations following prednisone or prednisolone administration to beagle dogs.
    Colburn WA; Sibley CR; Buller RH
    J Pharm Sci; 1976 Jul; 65(7):997-1001. PubMed ID: 957135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the absorption of prednisone and prednisolone disodium phosphate after rectal administration.
    Halvorsen S; Myren J; Aakvaag A
    Scand J Gastroenterol; 1969; 4(7):582-4. PubMed ID: 5374927
    [No Abstract]   [Full Text] [Related]  

  • 16. Bioavailability and reversible metabolism of prednisone and prednisolone in man.
    Garg V; Jusko WJ
    Biopharm Drug Dispos; 1994 Mar; 15(2):163-72. PubMed ID: 8011967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacokinetic comparison of two oral liquid glucocorticoid formulations.
    Kamada AK; Wiener MB; LaVallee NM; Scott MB; Selner JC; Szefler SJ
    Pharmacotherapy; 1997; 17(2):353-6. PubMed ID: 9085328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metabolism of glucocorticoids--in relation to increased anti-inflammatory activity].
    Mishina Y
    Horumon To Rinsho; 1972 Dec; 20(12):1053-62. PubMed ID: 4347634
    [No Abstract]   [Full Text] [Related]  

  • 19. The dose-dependent systemic availability of prednisone: one reason for the reduced biological effect of alternate-day prednisone.
    Frey FJ; Rüegsegger MK; Frey BM
    Br J Clin Pharmacol; 1986 Feb; 21(2):183-9. PubMed ID: 3954934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single dose of azathioprine does not affect the pharmacokinetics of prednisolone following oral prednisone.
    Frey FJ; Lozada F; Guentert T; Frey BM
    Eur J Clin Pharmacol; 1981 Feb; 19(3):209-12. PubMed ID: 7215419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.